Company news
OptimizeRx Corporation news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
May 3, 2022
OptimizeRx Releases First Environmental, Social and Governance (ESG) Report
April 28, 2022
OptimizeRx Sets First Quarter Fiscal 2022 Conference Call for Wednesday, May 4 at 4: 30 p.m. ET
April 20, 2022
UPDATE – Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients
April 19, 2022
1 in 3 Surveyed Physicians Say They Would Make a Different Treatment Choice If Medication Access Was Not a Factor
April 18, 2022
Financial Times Ranks OptimizeRx Amongst Americas’ Fastest-Growing Companies for the Third Consecutive Year
April 4, 2022
Augmedix Names William Febbo as New Member to its Board of Directors
March 28, 2022
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform
March 14, 2022
OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022
March 6, 2022
OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum
February 23, 2022
Top 10 Pharma Deploys OptimizeRx’s Digital Access Solution to Streamline Patient Therapy Initiation Challenges
February 21, 2022
OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance
February 14, 2022
OptimizeRx Sets Fourth Quarter and Full Year 2021 Conference Call for Thursday, February 24 at 4: 30 p.m. ET
February 9, 2022
OptimizeRx to Participate in Upcoming February Investor Conferences
January 30, 2022
OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased 53% in Continued Scale Up for Accelerated Growth
November 8, 2021
OptimizeRx Sets Third Quarter Fiscal 2021 Conference Call for Tuesday, November 9 at 4: 30 p.m. ET
October 26, 2021
OptimizeRx Appoints Seasoned Financial and Operational Executive, Edward Stelmakh as Chief Financial Officer and Chief Operations Officer
September 29, 2021
OptimizeRx Set to Join S&P SmallCap 600
September 28, 2021
OptimizeRx Announces Significant Platform Enhancement to Digitize Pharmaceutical Access Solutions
September 13, 2021
OptimizeRx Welcomes Andrew D’Silva as Senior Vice President of Corporate Finance
September 7, 2021
OptimizeRx and Demandbase Form Exclusive Account-Based-Experience (ABX) Partnership — Delivering Industry’s Most Powerful ABX Solution for Life Sciences
August 16, 2021
OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek Improved ROI Through Technology Adoption
August 3, 2021
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4: 30 p.m. ET
July 26, 2021
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients
July 13, 2021
OptimizeRx Named to LD Micro’s “Hall of Fame” As One of the Top 50 Performing Companies
May 31, 2021
OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health
May 5, 2021
OptimizeRx Sets First Quarter 2021 Conference Call for Thursday, May 6, 2021 at 4: 30 p.m. ET
April 27, 2021
OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care
April 26, 2021
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share
February 23, 2021
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4: 30 p.m. ET
February 17, 2021
OptimizeRx Announces Pricing of Public Offering of Common Stock
February 8, 2021
OptimizeRx Announces Proposed Public Offering of Common Stock
February 7, 2021
OptimizeRx’s TelaRep™ Recognized as One of the Most Innovative Products for Life Sciences by PM360
December 10, 2020
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
November 30, 2020
OptimizeRx Third Quarter 2020 Revenue Up 110% to Record $10.5 Million, Driving Non-GAAP Net Income of $1.1 million or $0.07 Per Share
November 8, 2020
OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4: 30 p.m. ET
October 25, 2020
OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%
October 12, 2020
OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Point-of-Care
September 14, 2020
OptimizeRx Enters Retail Pharmacies, Supporting Adherence by Bringing Prescription Savings Directly to Patients via Higi Smart Health Stations
August 19, 2020
OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half
August 4, 2020
OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach
July 26, 2020
OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4: 30 p.m. ET
July 22, 2020
OptimizeRx Appoints Greg Wasson, Former President and CEO of Walgreens Boots Alliance, to Its Board of Directors
July 20, 2020
OptimizeRx Engages UHY as New Independent Registered Public Accounting Firm
June 28, 2020
OptimizeRx Reports First Quarter 2020 Results; Revenue Up 46% to a Record $7.6 Million
May 3, 2020
OptimizeRx Sets First Quarter 2020 Conference Call for Monday, May 4, 2020 at 4: 30 p.m. ET
April 15, 2020
OptimizeRx Launches TelaRep™ to Support Physicians Treating Patients with Complex Diseases in COVID-19 World
April 1, 2020
OptimizeRx Launches Coronavirus Text Message Alerts
March 14, 2020
OptimizeRx Secures Two Additional Enterprise Clients on Newly Integrated Digital Healthcare Platform
March 10, 2020
OptimizeRx Launches ‘Digital Healthcare’ Webinar Series
March 9, 2020
Calls
The 5 newest of 22 calls. Every call is listed under its year.
- Optimizerx (NASDAQ:OPRX) Q2 2026 Earnings Call
Aug 12, 2026
Transcript - Optimizerx (NASDAQ:OPRX) Q1 2026 Earnings Call
May 12, 2026
Transcript - Optimizerx (NASDAQ:OPRX) Q4 2025 Earnings Call
Mar 5, 2026
Transcript - Optimizerx (NASDAQ:OPRX) Q3 2025 Earnings Call
Nov 6, 2025
Transcript - Optimizerx (NASDAQ:OPRX) Q2 2025 Earnings Call
Aug 7, 2025
Transcript
Decks
The 5 newest of 6 decks. Every deck is listed under its year.
- Investor Presentation (September 2026)
Investor deck · 17 slides · September 2026
- Q4 2025 Earnings Presentation
Earnings · 16 slides · Mar 5, 2026
- Investor Presentation (December 2018)
Investor deck · 25 slides · Dec 17, 2018
- Investor Presentation (March 2016)
Investor deck · 29 slides · Mar 18, 2016
- Investor Presentation (December 2013)
Investor deck · 20 slides · Dec 6, 2013